Predictors of quality of life among multiple sclerosis patients: a comprehensive analysis
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Background and purpose: Multiple sclerosis (MS) is a debilitating neurological disease of young people with substantial consequences on patients' quality of life (QOL). A variety of QOL instruments have been used to evaluate the efficacy of treatments. However, no study assessed the role of the different demographic, clinical, physical, social, economic and psychological parameters in the perception of patients with MS of their QOL. Methods: Two‐hundred and one consecutive patients attending outpatient clinics were prospectively studied and objectively assessed using Expanded Disability Status Scale (EDSS), 8‐m walk test, and Symbol Digit Modality Test. Patients completed the following questionnaires: MS QOL‐54, Hamilton Depression Rating Scale, Fatigue Severity Scale, Brief Pain Inventory Average Pain Score, Drug Side‐Effects Severity Scale, Social Support, Religiosity, Physiotherapy and Exercise, and Socioeconomic Profile. Overall, QOL, physical (PHCS) and mental (MHCS) health composite scores were computed as outcome measures from MSQOL‐54. Results: Depression, social support, religiosity, education years and living area predicted overall QOL by linear regression (R2 = 0.43). Unemployment and absence of fatigue correlated with poor and good QOL, respectively. Fatigue, pain, depression, EDSS, social support, MS type and anti‐cholinergic treatment predicted PHCS (R2 = 0.81). Fatigue, pain, depression, education years and social support predicted MHCS (R2 = 0.70). Conclusion: The QOL in patients with MS is not solely determined by physical disability, but rather by the level of social support, living area, depression, level of education, employment, fatigue and religiosity. Accordingly, we suggest that these should be evaluated in every patient with MS as they may be modified by targeted interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
Martin Bland, J., & Altman, D. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90837-8 · Cited by 47,965
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
Polman, C. H., Reingold, S. C., Edan, G., Filippi, M., Hartung, H., Kappos, L., Lublin, F. D., Metz, L. M., McFarland, H. F., O'Connor, P. W., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20703 · Cited by 5,017
A health-related quality of life measure for multiple sclerosis
Vickrey, B. G., Hays, R. D., Harooni, R., Myers, L. W., & Ellison, G. W. (1995) · Quality of Life Research · doi:10.1007/bf02260859 · Cited by 1,132 · cited 2×
“This questionnaire has a high test–retest reliability and internal consistency with evidence supporting its content and construct validity [26].”
BackgroundMethodBenedict, R. H. B., Wahlig, E., Bakshi, R., Fishman, I., Munschauer, F., Zivadinov, R., & Weinstock-Guttman, B. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.12.009 · Cited by 528
Quality of life in patients with multiple sclerosis
Janardhan, V., & Bakshi, R. (2002) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00312-x · Cited by 489
Depression and quality of life in multiple sclerosis: Depression and QoL in MS
Fruewald, S., Loeffler-Stastka, H., Eher, R., Saletu, B., & Baumhacki, U. (2001) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2001.00022.x · Cited by 211
McCabe, M. P., & McKern, S. (2002) · Journal of Clinical Psychology in Medical Settings · doi:10.1023/a:1020734901150 · Cited by 166 · cited 1×
“While QOL in patients with MS is expectedly poorer than for healthy subjects, it is also worse than other chronic diseases, such as epilepsy or diabetes [1,2].”
BackgroundGoretti, B., Portaccio, E., Zipoli, V., Hakiki, B., Siracusa, G., Sorbi, S., & Amato, M. P. (2009) · Neurological Sciences · doi:10.1007/s10072-008-0009-3 · Cited by 151
Hart, S., Fonareva, I., Merluzzi, N., & Mohr, D. C. (2005) · Quality of Life Research · doi:10.1007/s11136-004-1364-z · Cited by 128
Zivadinov, R., Zorzon, M., Tommasi, M. A., Nasuelli, D., Bernardi, M., Monti-Bragadin, L., & Cazzato, G. (2003) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(03)00225-9 · Cited by 81
Brochet, B., Deloire, M. S. A., Ouallet, J.-C., Salort, E., Bonnet, M., Jové, J., & Petry, K. G. (2009) · The Clinical Journal of Pain · doi:10.1097/ajp.0b013e3181891347 · Cited by 69
Influence of Interferon beta treatment on quality of life in multiple sclerosis patients
Simone, I. L., Ceccarelli, A., Tortorella, C., Bellacosa, A., Pellegrini, F., Plasmati, I., De Caro, M. F., Lopez, M., Girolamo, F., & Livrea, P. (2006) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-4-96 · Cited by 67
Cited by
Assessment and impact of cognitive impairment in multiple sclerosis: An overview
Macías Islas, M. Á., & Ciampi, E. (2019) · Biomedicines · doi:10.3390/biomedicines7010022 · Cited by 144
“financial support for medication, and in some countries access to work benefits and social security [23], so cognition should be a priority in an era with highly active treatments reducing relapses and new lesions, and even new horizons in preventing accumulation of physical disability with new disease modifying treat…”
Backgroundvan Groenestijn, A. C., Kruitwagen-van Reenen, E. T., Visser-Meily, J. M. A., van den Berg, L. H., & Schröder, C. D. (2016) · Health and Quality of Life Outcomes · doi:10.1186/s12955-016-0507-6 · Cited by 92
“These findings are mirrored in other diseases such as Multiple Sclerosis [57] and advanced cancer [58].”
ResultWilski, M., Gabryelski, J., Brola, W., & Tomasz, T. (2019) · Disability and health journal · doi:10.1016/j.dhjo.2019.06.003 · Cited by 78
Quality of life and coping strategies in Lebanese multiple sclerosis patients: a pilot study
Farran, N., Ammar, D., & Darwish, H. (2016) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2015.12.003 · Cited by 42
Brola, W., Sobolewski, P., Fudala, M., Flaga, S., Jantarski, K., Ryglewicz, D., & Potemkowski, A. (2016) · Patient Preference and Adherence · doi:10.2147/ppa.s109520 · Cited by 35
Metadata
- Authors
- Yamout, B., Issa, Z., Herlopian, A., El Bejjani, M., Khalifa, A., Ghadieh, A. S., & Habib, R. H.
- Venue
- European Journal of Neurology
- Publisher
- Wiley
- Published
- 2013-01-08
- Volume
- 20
- Issue
- 5
- Pages
- 756-764
- ISSN
- 1351-5101 (ISSN-L)
- 1468-1331
- OpenAlex
- W2115945950
- Cited by
- 137
- References
- 12
- FWCI
- 7.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.